These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38460056)

  • 1. Abbreviated magnetic resonance imaging in hepatocellular carcinoma surveillance: A review.
    Ramegowda R; Gupta P
    Indian J Gastroenterol; 2024 Mar; ():. PubMed ID: 38460056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abbreviated MRI for hepatocellular carcinoma screening: A systematic review and meta-analysis.
    Gupta P; Soundararajan R; Patel A; Kumar-M P; Sharma V; Kalra N
    J Hepatol; 2021 Jul; 75(1):108-119. PubMed ID: 33548385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-Analysis of the Accuracy of Abbreviated Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance: Non-Contrast versus Hepatobiliary Phase-Abbreviated Magnetic Resonance Imaging.
    Kim DH; Choi SH; Shim JH; Kim SY; Lee SS; Byun JH; Choi JI
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34198589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of non-contrast abbreviated MRI and alpha foetoprotein has high performance for hepatocellular carcinoma screening.
    Girardet R; Dubois M; Manasseh G; Jreige M; Du Pasquier C; Canniff E; Gulizia M; Bonvin M; Aleman Y; Taouli B; Fraga M; Dromain C; Vietti Violi N
    Eur Radiol; 2023 Oct; 33(10):6929-6938. PubMed ID: 37464111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative approach of hepatocellular carcinoma surveillance: abbreviated MRI.
    Brunsing RL; Fowler KJ; Yokoo T; Cunha GM; Sirlin CB; Marks RM
    Hepatoma Res; 2020; 6():. PubMed ID: 33381651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening.
    Vietti Violi N; Lewis S; Liao J; Hulkower M; Hernandez-Meza G; Smith K; Babb JS; Chin X; Song J; Said D; Kihira S; Sirlin CB; Reeder SB; Bashir MR; Fowler KJ; Ferket BS; Sigel K; Taouli B
    Eur Radiol; 2020 Nov; 30(11):6003-6013. PubMed ID: 32588209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Utility Analysis of Non-Contrast Abbreviated Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance in Cirrhosis.
    Decharatanachart P; Pan-Ngum W; Peeraphatdit T; Tanpowpong N; Tangkijvanich P; Treeprasertsuk S; Rerknimitr R; Chaiteerakij R
    Gut Liver; 2024 Jan; 18(1):135-146. PubMed ID: 37560799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Landscape and Future Perspectives of Abbreviated MRI for Hepatocellular Carcinoma Surveillance.
    Park HJ; Seo N; Kim SY
    Korean J Radiol; 2022 Jun; 23(6):598-614. PubMed ID: 35434979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abbreviated-protocol screening MRI vs. complete-protocol diagnostic MRI for detection of hepatocellular carcinoma in patients with cirrhosis: An equivalence study using LI-RADS v2018.
    Khatri G; Pedrosa I; Ananthakrishnan L; de Leon AD; Fetzer DT; Leyendecker J; Singal AG; Xi Y; Yopp A; Yokoo T
    J Magn Reson Imaging; 2020 Feb; 51(2):415-425. PubMed ID: 31209978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abbreviated MRI with second shot arterial phase for HCC evaluation: modified version of LI-RADS and recall reduction strategy.
    Kim JW; Lee CH; Kim KA; Lee J; Park YS
    Eur Radiol; 2023 Jun; 33(6):4401-4411. PubMed ID: 36562784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abbreviated Liver Magnetic Resonance Imaging Protocols and Applications.
    Altinmakas E; Taouli B
    Radiol Clin North Am; 2022 Sep; 60(5):695-703. PubMed ID: 35989038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abbreviated magnetic resonance imaging vs ultrasound for surveillance of hepatocellular carcinoma in high-risk patients.
    Park HJ; Kim SY; Singal AG; Lee SJ; Won HJ; Byun JH; Choi SH; Yokoo T; Kim MJ; Lim YS
    Liver Int; 2022 Aug; 42(9):2080-2092. PubMed ID: 34817921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Performance of Abbreviated MRI for HCC Detection in Patients with Non-alcoholic Fatty Liver Disease.
    Soundararajan R; Pooja AB; Gupta P; Gulati A; Kalra N; Singh S; Premkumar M; Taneja S; Jearth V; Sharma V; Duseja A
    J Clin Exp Hepatol; 2024; 14(1):101276. PubMed ID: 38076364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of noncontrast, dynamic, and hepatobiliary phase abbreviated MRI protocols for detection of hepatic malignancies.
    Lee JH; Kim YK; Min JH; Cha D; Hwang JA; Ahn S
    Clin Imaging; 2023 Sep; 101():206-214. PubMed ID: 37421716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abbreviated MRI for Secondary Surveillance of Recurrent Hepatocellular Carcinoma After Presumed Curative Treatment.
    Jeon SK; Lee DH; Hur BY; Park SJ; Kim SW; Park J; Suh KS; Lee KW; Yi NJ; Han JK
    J Magn Reson Imaging; 2023 Nov; 58(5):1375-1383. PubMed ID: 36825827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: A prospective study.
    Huang DQ; Fowler KJ; Liau J; Cunha GM; Louie AL; An JY; Bettencourt R; Jung J; Gitto Z; Hernandez C; Lopez SJ; Gupta H; Sirlin CB; Marks RM; Loomba R
    Aliment Pharmacol Ther; 2022 Apr; 55(7):820-827. PubMed ID: 35229334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abbreviated MRI for Hepatocellular Carcinoma Surveillance - A Systematic Review and Meta-analysis.
    Maung ST; Deepan N; Decharatanachart P; Chaiteerakij R
    Acad Radiol; 2024 Aug; 31(8):3142-3156. PubMed ID: 38413315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma detection: diagnostic performance of a simulated abbreviated MRI protocol combining diffusion-weighted and T1-weighted imaging at the delayed phase post gadoxetic acid.
    Besa C; Lewis S; Pandharipande PV; Chhatwal J; Kamath A; Cooper N; Knight-Greenfield A; Babb JS; Boffetta P; Padron N; Sirlin CB; Taouli B
    Abdom Radiol (NY); 2017 Jan; 42(1):179-190. PubMed ID: 27448609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis.
    Nahon P; Najean M; Layese R; Zarca K; Segar LB; Cagnot C; Ganne-Carrié N; N'Kontchou G; Pol S; Chaffaut C; Carrat F; Ronot M; Audureau E; Durand-Zaleski I; ; ; ;
    JHEP Rep; 2022 Jan; 4(1):100390. PubMed ID: 34977518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter-reader agreement of abbreviated magnetic resonance imaging for hepatocellular carcinoma detection: a systematic review and meta-analysis.
    Kim DH; Choi SH; Lee JS; Choi JI
    Abdom Radiol (NY); 2022 Jan; 47(1):123-132. PubMed ID: 34633497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.